Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124154892 | 12415489 | 2 | F | 201605 | 20160614 | 20160530 | 20160705 | PER | US-PFIZER INC-2016251639 | PFIZER | 47.00 | YR | F | Y | 67.00000 | KG | 20160705 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124154892 | 12415489 | 1 | PS | Genotropin MQ | SOMATROPIN | 1 | 0.2 MG PER SYRINGE INJECTION DAILY FOR A WEEK, THEN EVERY 3RD DAY | M77206 | 20280 | .2 | MG | POWDER FOR SOLUTION FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124154892 | 12415489 | 1 | Dysphonia |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124154892 | 12415489 | Asthenia | |
124154892 | 12415489 | Insomnia | |
124154892 | 12415489 | Pre-existing condition improved | |
124154892 | 12415489 | Product use issue | |
124154892 | 12415489 | Therapeutic response unexpected |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124154892 | 12415489 | 1 | 201605 | 0 |